Harmonic Discovery
Multi-targeted therapeutics to treat complex diseases
We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.
- Website
- harmonicdiscovery.com
- City
- New York City
- Country
- United States
- YC batch
- Summer 2021
- Team
- 8 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in New York City
Ro$5bn
Health technology. Valued at $5bn (March 2021).
Noom$3.7bn
Healthcare. Valued at $3.7bn (May 2021).
Headway$2.3bn
Healthcare. Valued at $2.3bn (July 2024).
Sword Health$2bn
Health. Valued at $2bn (November 2021).
H1
Connecting stakeholders across the healthcare ecosystem.
Opentrons
We make robots for biologists.
Claim this profile
Free and instant: prove you run harmonicdiscovery.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Harmonic Discovery across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Harmonic Discovery's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
